Your browser is no longer supported. Please, upgrade your browser.
NEW! We've added Bitcoin charts to our Forex section. ×
Settings
ESRX [NASD]
Express Scripts Holding Company
IndexS&P 500 P/E31.85 EPS (ttm)2.84 Insider Own0.20% Shs Outstand729.29M Perf Week3.51%
Market Cap65.96B Forward P/E15.01 EPS next Y6.03 Insider Trans-8.06% Shs Float727.57M Perf Month4.09%
Income2.12B PEG2.48 EPS next Q1.40 Inst Own88.10% Short Float10.22% Perf Quarter4.29%
Sales102.10B P/S0.65 EPS this Y14.30% Inst Trans-0.30% Short Ratio18.21 Perf Half Y13.80%
Book/sh28.29 P/B3.20 EPS next Y10.75% ROA4.00% Target Price95.10 Perf Year28.74%
Cash/sh1.24 P/C72.82 EPS next 5Y12.83% ROE10.40% 52W Range65.08 - 90.99 Perf YTD6.81%
Dividend- P/FCF16.45 EPS past 5Y11.20% ROI7.60% 52W High-0.60% Beta1.29
Dividend %- Quick Ratio0.50 Sales past 5Y32.50% Gross Margin8.20% 52W Low38.97% ATR1.61
Employees29500 Current Ratio0.60 Sales Q/Q5.10% Oper. Margin4.50% RSI (14)67.75 Volatility1.62% 1.98%
OptionableYes Debt/Eq0.60 EPS Q/Q42.90% Profit Margin2.10% Rel Volume0.86 Prev Close90.20
ShortableYes LT Debt/Eq0.52 EarningsApr 28 AMC Payout0.00% Avg Volume4.08M Price90.44
Recom2.20 SMA204.39% SMA505.52% SMA20012.41% Volume3,501,299 Change0.27%
May-20-15Initiated Robert W. Baird Neutral $94
Mar-10-15Reiterated RBC Capital Mkts Outperform $82 → $87
Feb-24-15Reiterated Mizuho Buy $94 → $98
Feb-24-15Reiterated Maxim Group Buy $90 → $109
Jan-28-15Downgrade FBR Capital Outperform → Mkt Perform
Jan-08-15Reiterated Mizuho Buy $82 → $94
Dec-16-14Reiterated Oppenheimer Outperform $82 → $88
Dec-15-14Reiterated UBS Buy $82 → $96
Dec-04-14Reiterated Deutsche Bank Hold $76 → $88
Dec-03-14Reiterated Barclays Overweight $83 → $94
Oct-30-14Reiterated RBC Capital Mkts Outperform $73 → $82
Jul-30-14Reiterated FBR Capital Outperform $79 → $74
Jul-28-14Reiterated UBS Buy $90 → $82
May-01-14Reiterated Maxim Group Buy $92 → $90
Apr-30-14Reiterated Mizuho Buy $86 → $82
Mar-06-14Reiterated Deutsche Bank Hold $75 → $79
Mar-05-14Reiterated RBC Capital Mkts Outperform $72 → $84
Mar-05-14Initiated Barclays Overweight $85
Feb-21-14Reiterated FBR Capital Outperform $75 → $83
Feb-19-14Reiterated Maxim Group Buy $80 → $92
May-22-15 07:43AM  In a quiet stock market, whispers of an M&A wave
05:47AM  Upside plays in Express Scripts
May-21-15 07:35PM  As Express Scripts Attacks Costs, Investors Will Profit at Barrons.com
May-20-15 05:45AM  Coverage initiated on Express Scripts by Robert W. Baird
May-19-15 11:02AM  Annual Healthcare Cost For Family Of Four Now At $24,671 at Forbes
May-13-15 01:52PM  How much do Americans spend on drugs?
12:30PM  More M&A Could be Coming for This Healthcare ETF
09:00AM  Drug 'super spenders' rack up $52 billion last year
07:00AM  5 Hated Stocks That Could Pop in May at TheStreet
06:44AM  Your prescriptions costs what?
06:00AM  Express Scripts Research Highlights $52 Billion Challenge for U.S. Healthcare System PR Newswire
12:01AM  Number of Americans using $100,000 in medicines triples -Express Scripts
12:01AM  500,000 Americans spend $50K on medicine each year at CNBC
12:00AM  Drug Costs Top $50K A Year For Half Million Americans at Forbes
May-08-15 04:17PM  EXPRESS SCRIPTS HOLDING CO. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
03:35PM  Cancer drug spending hit $100 billion in 2014. Heres why itll soon be much higher at Fortune
May-06-15 06:55AM  New ways to jump over biotech's speed bumps
May-05-15 04:23PM  EXPRESS SCRIPTS HOLDING CO. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and
11:10AM  Express Scripts Goes On The Aggressive To Bargain For Lower Cancer Drug Prices
10:21AM  SCAN Health Plan, Express Scripts' Quality Network Improves Medicare Beneficiary Health at noodls
10:00AM  SCAN Health Plan, Express Scripts' Quality Network Improves Medicare Beneficiary Health PR Newswire
07:16AM  Express Scripts draws call buyers
May-01-15 05:47PM  Express Scripts unit to pay $60 mln over Novartis kickbacks, US says Reuters
03:06PM  Express Scripts to Pay $60M to Settle Novartis Kickback Scheme at The Wall Street Journal
02:33PM  Why Medicare's List Of Costly Drugs Is Kind Of Bogus at Forbes
08:58AM  Express Scripts unit to pay $45 million to U.S. over Novartis kickback scheme Reuters
Apr-30-15 04:32PM  Omnicare Draws Interest From CVS and Express Scripts
02:56PM  Omnicare draws buyout interest from CVS, Express Scripts - Bloomberg Reuters
02:11PM  Omnicare Said to Draw Interest From CVS and Express Scripts at Bloomberg
07:15AM  5 things to start the day: More Express Scripts closings and only you can prevent Florida wildfires at bizjournals.com
Apr-29-15 09:06PM  Express Scripts Announces Accelerated Share Repurchase Transaction PR Newswire
05:30PM  Stocks End Lower After Fed, GDP Data
03:13PM  Express Scripts Holding (ESRX) Earnings Report: Q1 2015 Conference Call Transcript at TheStreet
12:00PM  Stocks Lower After GDP Data
09:57AM  Express Scripts says controlling cancer-drug costs a tough new focus
09:45AM  Express Scripts Posts In-line Q1 Earnings, Revenues Beat - Analyst Blog
08:30AM  Express Scripts Holding Co Earnings Call scheduled for 8:30 am ET today
Apr-28-15 07:00PM  Express Scripts meets 1Q profit forecasts
05:43PM  Twitter shares slip after hours following big selloff at MarketWatch
04:52PM  Express Scripts Announces 1st Quarter Results; Announces New Credit Agreement; Narrows 2015 Guidance Range; Maintains Mid-Point at noodls
04:28PM  EXPRESS SCRIPTS HOLDING CO. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material
04:20PM  Express Scripts shares rise on outlook at MarketWatch
04:16PM  Express Scripts (ESRX) Stock Gains in After-Hours Trading After Earnings Report at TheStreet
04:01PM  Express Scripts Announces 1st Quarter Results; Announces New Credit Agreement; Narrows 2015 Guidance Range; Maintains Mid-Point PR Newswire
02:27PM  Will Gilead (GILD) Miss Q1 Earnings on Weak HCV Sales? - Analyst Blog
12:35PM  What's Coming For Express Scripts?
12:06PM  Humana Realigns Healthcare Services Segment in 1Q15
07:07AM  Q1 2015 Express Scripts Holding Co Earnings Release - After Market Close
Apr-27-15 03:12PM  Will Express Scripts (ESRX) Disappoint Earnings in Q1? - Analyst Blog
Apr-21-15 08:45AM  Workers' Compensation Prescription Drug Spend Increased 1.9 Percent in 2014, Stabilized by Effective Utilization Management Programs at noodls
08:30AM  Workers' Compensation Prescription Drug Spend Increased 1.9 Percent in 2014, Stabilized by Effective Utilization Management Programs PR Newswire
Apr-20-15 04:10PM  UnitedHealth Groups Optum Posts Healthy 1Q15 Operating Earnings
01:01PM  John Shapiros Value Investing Picks Pay Off Big Time In First Quarter at Insider Monkey
09:01AM  These Five Positions Hurt Hedge Funds the Most Last Week
Apr-18-15 11:10AM  Why Walgreens Won't Buy A PBM Anytime Soon at Forbes
Apr-16-15 06:14PM  AbbVie's HCV Treatment Granted Priority Review in Japan - Analyst Blog
05:54PM  Why CVS Health And McKesson May Be Good Stock Picks at Investor's Business Daily
02:12PM  Exciting time for drug breakthroughs: Merck CEO
06:27AM  UnitedHealthcare Q1 earnings beats Street
Apr-10-15 09:30AM  Will Walgreens make a run for Express Scripts? at bizjournals.com
Apr-09-15 06:00PM  Express Scripts, Silicon Motion, Apogee Break Out at Investor's Business Daily
06:00PM  Cramer: Invest in best of breed
05:10PM  Gap shares decline as sales fall at namesake store at MarketWatch
03:29PM  Express Scripts climbs as Walgreens states interest in deals
10:41AM  Stocks Wobble At Starting Line; Express Scripts Up, Altera Dips at Investor's Business Daily
Apr-08-15 04:55PM  Express Scripts Holding Company Announces First Quarter 2015 Earnings Conference Call at noodls
04:30PM  Express Scripts Holding Company Announces First Quarter 2015 Earnings Conference Call GlobeNewswire
Apr-04-15 12:01AM  After Rising 80%, UnitedHealth Looks Pricey at Barrons.com
Apr-01-15 09:30AM  The Zacks Analyst Blog Highlights: UnitedHealth Group, Catamaran, CVS Health, Express Scripts and Rite Aid - Press Releases
07:50AM  SIOR chapter announces deals of the year for western Pennsylvania at bizjournals.com
Mar-31-15 02:43PM  Express Scripts (ESRX) Stock Is Up Today on Heavy Trading Volume at TheStreet
02:40PM  13 CEOs who hang out at the White House
02:20PM  Breakout time for Express Scripts?
02:00PM  UnitedHealth Arm to Boost Pharmacy Benefits with Catamaran - Analyst Blog
11:06AM  Post-UNH Deal, Spotlight on Pharmacy Benefit Stocks - Analyst Blog
12:29AM  [$$] UnitedHealth to Buy Catamaran for $12.8 Billion in Cash at The Wall Street Journal
Mar-30-15 11:00PM  Catamaran Corporation -- Moody's puts Catamaran's ratings on review for upgrade following news of acquisition by OptumRx at Moody's
07:41PM  UnitedHealth Pays $12.8 Bil To Double Prescription Clients
06:30PM  UnitedHealth Group Incorporated -- Moody's affirms UnitedHealth's ratings (sr. debt at A3) on announced acquisition; outlook changed to negative from stable at Moody's
06:10PM  UnitedHealth to Buy Catamaran for $12.8 Billion at The Wall Street Journal
05:32PM  UnitedHealth bulks up for prescription drug cost battle
05:30PM  Stocks End Higher on China Easing Hopes, M&A Activity
03:22PM  UnitedHealth-Catamaran deal sets up healthcare M&A chessboard
02:19PM  Fight Over High-Cost Drugs to Intensify After Catamaran Deal at Bloomberg
02:03PM  UnitedHealth's $12.8B deal
01:20PM  UnitedHealth: changing the channel at Financial Times
01:00PM  Catamaran leads Nasdaq
12:00PM  Stocks Rise After China Easing Hopes, M&A Activity
11:40AM  UnitedHealth: Catamaran Acquisition 'Checks Three Important Boxes' at Barrons.com
09:54AM  UnitedHealth to buy pharmacy benefits manager Catamaran at Los Angeles Times
09:09AM  UnitedHealth's $12.8 Billion Answer To Expensive Prescription Drugs at Forbes
09:00AM  UnitedHealth Acquires Catamaran, Creating a Top-Tier PBM at Morningstar
08:02AM  UnitedHealth to buy pharmacy benefits manager Catamaran AP
Mar-27-15 10:28AM  5 Big Breakout Stocks to Trade for Big Gains: Must-See Charts at TheStreet
Mar-26-15 05:30PM  Biotech's rough ride over?
Mar-18-15 10:28AM  The Scariest Health Care Statistic of 2014
09:30AM  Zacks Industry Outlook Highlights: Orexigen, MannKind, Amgen, Medivation and Express Scripts - Press Releases
Mar-17-15 08:42AM  Critical Reports Mount On Hepatitis C Pill Costs at Forbes
Mar-16-15 04:00PM  Prescription drug spending has gone through the roof and now we know why
12:57PM  Buy These Stocks to Avoid Dollar Damage, Goldman Sachs Says at Barrons.com
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company operates through two segments, PBM and Other Business Operations. The company's PBM segment's services include clinical solutions to enhance health outcomes, such as adherence, case coordination, and personalized medicine; specialized pharmacy care; home delivery pharmacy; specialty pharmacy, including the distribution of fertility pharmaceuticals that require special handling or packaging; and retail network pharmacy administration. It also provides benefit design consultation; drug utilization review; drug formulary management; an array of Medicare, Medicaid, and health insurance marketplace; administration of a group purchasing organization; and consumer health and drug information services. In addition, the company distributes specialty pharmaceuticals and medical supplies to providers, clinics, and hospitals; and offers consulting services for pharmaceutical manufacturers to collect scientific evidence to guide the use of medicines, as well as case management approach to manage care by integrating pre-certification, case management, and discharge planning services for patients. It serves managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation plans, government health programs, office-based oncologists, renal dialysis clinics, ambulatory surgery centers, primary care physicians, retina specialists, and others. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in St. Louis, Missouri.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MYERS WOODROW A JRDirectorMay 08Option Exercise54.0314,342774,92926,720May 12 04:14 PM
MYERS WOODROW A JRDirectorMay 08Sale85.3214,3421,223,64512,378May 12 04:14 PM
BENANAV GARY GDirectorMay 04Option Exercise30.8313,128404,73656,139May 06 04:01 PM
BENANAV GARY GDirectorMay 04Sale87.3910,000873,85046,139May 06 04:01 PM
Norton David ASVP, Specialty & Supply ChainMay 01Option Exercise49.507,000346,46523,280May 05 04:07 PM
Wade Sara ESr. VP, Ch. Human Res. Off.May 01Sale86.5312,0001,038,30028,599May 05 04:09 PM
Norton David ASVP, Specialty & Supply ChainMay 01Sale86.5312,0291,040,80911,251May 05 04:07 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Mar 02Sale84.392,674225,6598,291Mar 03 04:15 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Feb 25Sale87.315,864511,98610,965Feb 26 04:03 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Feb 24Option Exercise47.6121,7391,034,99438,568Feb 26 04:03 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Feb 24Sale87.6221,7391,904,77016,829Feb 26 04:03 PM
Ebling Keith J.Exec. VP and General CounselDec 02Sale84.2510,000842,5000Dec 03 04:04 PM
Miller Steven BSr. VP & Chief Med. OfficerDec 01Sale83.574,896409,14416,521Dec 03 04:07 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Nov 28Option Exercise47.6110,800514,18830,657Dec 01 04:03 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Nov 28Sale82.9610,800895,94619,857Dec 01 04:03 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Nov 21Option Exercise47.6110,874517,71130,731Nov 25 04:38 PM
MAC MAHON THOMAS PDirectorNov 21Option Exercise35.8512,694455,01654,066Nov 25 04:40 PM
MAC MAHON THOMAS PDirectorNov 21Sale80.9312,6941,027,35141,372Nov 25 04:40 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Nov 21Sale81.5010,874886,23119,857Nov 25 04:38 PM
PARKER JOHN ODirectorNov 17Option Exercise33.3025,822859,75365,503Nov 18 05:04 PM
PARKER JOHN ODirectorNov 17Sale78.7525,8222,033,43139,681Nov 18 05:04 PM
Breen Maura CDirectorNov 07Option Exercise30.8313,128404,73630,438Nov 10 04:16 PM
Breen Maura CDirectorNov 07Sale77.8013,1281,021,34517,310Nov 10 04:16 PM
IGNACZAK EDWARD BEVPSep 05Sale75.289,886744,21675,996Sep 09 05:01 PM
STERNBERG SEYMOURDirectorAug 28Option Exercise54.3015,508842,07920,277Sep 02 04:07 PM
STERNBERG SEYMOURDirectorAug 28Sale74.1215,5081,149,3914,769Sep 02 04:07 PM
Ebling Keith J.Exec. VP and General CounselAug 25Sale75.5010,000755,00010,000Aug 26 04:04 PM
BENANAV GARY GDirectorAug 05Option Exercise35.8512,694455,01655,705Aug 07 04:08 PM
Wade Sara ESr. VP, Ch. Human Res. Off.Aug 05Option Exercise53.0520,0001,061,00049,532Aug 06 04:10 PM
Wade Sara ESr. VP, Ch. Human Res. Off.Aug 05Sale70.4420,0001,408,80029,532Aug 06 04:10 PM
BENANAV GARY GDirectorAug 05Sale70.8212,694898,98943,011Aug 07 04:08 PM
Norton David ASenior VP, Supply ChainAug 04Sale71.021,27690,6270Aug 06 04:13 PM
Breen Maura CDirectorAug 01Option Exercise35.8512,694455,01630,283Aug 05 04:55 PM
Breen Maura CDirectorAug 01Sale69.9412,694887,75517,589Aug 05 04:55 PM
PAZ GEORGEChairman & CEOJun 13Option Exercise26.68681,50818,179,3841,469,761Jun 17 05:04 PM
PAZ GEORGEChairman & CEOJun 13Sale71.21681,50848,530,185788,253Jun 17 05:04 PM
WENTWORTH TIMOTHY CPresidentMay 27Option Exercise47.25127,1896,009,516228,492May 29 05:03 PM
WENTWORTH TIMOTHY CPresidentMay 27Sale70.47105,6777,447,058122,815May 29 05:03 PM